What Is CBD for dogs?
What is CBD oil?
Why your veterinarian may not be interested in discussing CBD oil with you?
How does CBD affect dogs?
Is CBD safe for dogs?
What to watch out for when you give your dog CBD!
CBD is natural and in humans, high doses have been shown to be safe. There are still some negative side effects that may affect your dog. These include:
Low blood pressure
Lethargy or drowsiness
Interactions with other medications
Risks of Using CBD Oil for dogs
Hemp Oil vs Marijuana
Your dog won't get “High” from CBD oil.
What Medical Conditions can be helped with CBD for dogs?
CBD can treat Seizures and Epilepsy
CBD relieves Pain
CBD can prevent & fight cancer
CBD and Inflammatory Bowel Disease
CBD Oil and Chronic Inflammation : Auto-Immune Disorders
CBD protects the nervous system
CBD's role in Cardiovascular Health
CBD oil for Arthritis or Stiffness in dogs
A recent study by Cornell University researchers has found that CBD given twice per day can improve comfort and mobility in dogs that have naturally occurring osteoarthritis. In the same paper, in 55% of other studies involving non-steroidal anti-inflammatory medications (NSAIDs) the patients had adverse effects. In this study, no side effects were reported when patients were given CBD. Some of these results show that CBD may be an alternative treatment option for pet parents.
CBD oil and anxiety
How to choose the best and safest CBD oil for your dog?
4 Tips for Picking the Right CBD supplements for your dog
Price and potency
Analysis and verification
How to introduce CBD to your dog ?
Cannabis (CBD) oil For Dogs
CBD Dog Treats
Benefits of CBD Dog Treats
CBD oil Dosage for Dogs
How long does it take for CBD oil to work for dogs?
Dangers of a CBD Oil Overdose
Is it legal to give your dog CBD oil?
So, where do we stand on the use of CBD oil in our pets?
One request from Speedy
Dr. Edele Grey put so much effort writing this blog post to provide value to the dog parent community. It’ll be very helpful for me, if you consider sharing it on social media networks.
SHARING IS ♥️
Russo, E.B. (2007) History of cannabis and its preparations in saga, science, and sobriquet. Chem. Biodivers. 4:1614-1648
Mechoulam, R., L.A. Parker & R. Gallily (2002) Cannabidiol: An overview of some pharmacological aspects. J. Clin. Pharmacol. 42:11S-19S
Gamble, L-J, J.M. Boesch, C.W. Frye, W.S. Schwark, S. Mann, L. Wolfe, H. Brown, E.S. Berthelsen & J.J. Wakshlag (2018) Pharmacokinetics, safety and clinical efficacy of cannabidiol treatment in osteoarthritic dogs. Front. Vet. Sci. 5:165
Kogan, L., R. Schoenfeld-Tacher, P. Hellyer and M. Rishniw (2019) US Veterinarians’ knowledge, experience and perception regarding the use of cannabidiol for canine medical conditions. Front. Vet. Sci. 5:338
Bergamaschi, M.M., R.H. Queiroz, Q.W. Zuardi and J.A. Crippa (2011) Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr. Drug Saf. 6(4):237-249
Meola, S.D., C.C. Tearney, S.A. Haas, T.B. Hackett and E.M. Mazzaferro (2012) Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010). J. Vet. Emerg. Crit. Care 22(6):690-696
Devinsky, O., J. Sullivan, D. Friedman, E. Thiele, E. Marsh, L. Laux, J. Hedlund, N. Tilton, J. Bluvstein and M. Cilio (2014) Efficacy and safety of epidolex (cannabidiol) in children and young adults with treatment-resistant epilepsy: Initial data from an expanded access program. American Epilepsy Society Abstracts
Bartner, L.R., S. McGrath, S. Rao, L.K. Hyatt and L.A. Wittenburg (2018) Pharmacokinetics of cannabidiol administered by 3 delivery methods at 3 different dosages to healthy dogs. Can. J. Vet. Res. 82(3):178-183
Porter, B.E. and C. Jacobson (2013) Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav. 29(3):574-577
Li, K. J.Y. Feng, Y.Y. Li, B. Yeuce, X.H. Lin, Y.N. Li, Y.J. Feng and M. Storr (2013) Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice. Pancreas 42(1):123-9
Crippa, J.A., G.N. Derenusson, T.B. Ferrari, L. Wichert-Ana, F.L. Duran, R. Martin-Santos, M.V. Simões, S. Bhattacharyya, P. Fusar-Poli, Z. Atakan, A. Santos Filho, M.C. Freitas-Ferrari, P.K. McGuire, A.W. Zuardi, G.F. Busatto and J.E. Hallak (2011) Neural basis for anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J. Psychopharmacol. 25(1):121-130
Xiong, W., C. Tanxing, K. Cheng, F. Yang, S. Chen, D. Willenbring, Y. Guan, H. Pan, K. Ren, Y. Xu and L. Zhang (2012) Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors. J. Exp. Med. 209(6):1121-1134
Lötsch, J., I. Weyer-Menkhoff and I. Tegeder (2018) Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings. Eur. J. Pain. 22(3):471-484
Currais, A., O. Quehenberger, A.M. Armando, D. Daugherty, P. Maher and D. Schubert (2016) Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids. NPJ Aging Mech. Dis. 16012
Sindiswa, T.L. and R.M. Lesetja (2016) Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells. BMC Compl. Altern. Med. 16(1):335
Haustein, M., R. Ramer, M. Linnebacher, K. Manda and B. Hinz (2014) Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1. Biochem. Pharmacol. 92(2):312-325
Izzo, A.A. and M. Camilleri (2009) Cannabinoids in intestinal inflammation and cancer. Pharmacol. Res. 60(2):117-125
Capasso, R., F. Borrelli, G. Aviello, B. Romano, C. Scalisi, F. Capasso and A.A. Izzo (2008) Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice. Br. J. Pharmacol. 154(5):1001-1008
Elliott, D.M., N. Singh, M. Nagarkatti and P.S. Nagarkatti (2018) Cannabidiol attenuates experimental autoimmune encephalomyelitis model of multiple sclerosis through induction of myeloid-derived suppressor cells. Front. Immunol. 9:1782
Hampson, A.J., M. Grimaldi, J. Axelrod and D. Wink (1998) Cannabidiol and (-)Δ9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. U.S.A. 95(14):8268-8273
Iuvone, T., G. Esposito, R. Esposito, R. Santamaria, M. Di Rosa and A.A. Izzo (2004) Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J. Neurochem. 89(1):134-141
Stanley, C.P., W.H. Hind and S.E. O’Sullivan (2013) Is the cardiovascular system a therapeutic target for cannabidiol? Br. J. Clin. Pharmacol. 75(2):313-322
Walsh, S.K., C.Y. Hepburn, K.A. Kane and C.L. Wainwright (2010) Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion. Br. J. Pharmacol. 160(5):1234-1242